Nathan J Dowden - Net Worth and Insider Trading
Nathan J Dowden Net Worth
The estimated net worth of Nathan J Dowden is at least $2 Million dollars as of 2024-11-05. Nathan J Dowden is the President & COO of Entrada Therapeutics Inc and owns about 125,149 shares of Entrada Therapeutics Inc (TRDA) stock worth over $2 Million. Details can be seen in Nathan J Dowden's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nathan J Dowden has not made any transactions after 2024-09-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nathan J Dowden
Nathan J Dowden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nathan J Dowden owns 1 companies in total, including Entrada Therapeutics Inc (TRDA) .
Click here to see the complete history of Nathan J Dowden’s form 4 insider trades.
Insider Ownership Summary of Nathan J Dowden
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRDA | Entrada Therapeutics Inc | 2024-09-26 | Chief Operating Officer |
Nathan J Dowden Latest Holdings Summary
Nathan J Dowden currently owns a total of 1 stock. Nathan J Dowden owns 125,149 shares of Entrada Therapeutics Inc (TRDA) as of September 26, 2024, with a value of $2 Million.
Latest Holdings of Nathan J Dowden
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics Inc | 2024-09-26 | 125,149 | 17.86 | 2,234,535 |
Holding Weightings of Nathan J Dowden
Nathan J Dowden Form 4 Trading Tracker
According to the SEC Form 4 filings, Nathan J Dowden has made a total of 15 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Entrada Therapeutics Inc is the sale of 847 shares on September 26, 2024, which brought Nathan J Dowden around $13,552.
Insider Trading History of Nathan J Dowden
- 1
Nathan J Dowden Trading Performance
Nathan J Dowden Ownership Network
Ownership Network List of Nathan J Dowden
Ownership Network Relation of Nathan J Dowden
Nathan J Dowden Owned Company Details
What does Entrada Therapeutics Inc do?
Who are the key executives at Entrada Therapeutics Inc?
Nathan J Dowden is the Chief Operating Officer of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Scientific Officer Natarajan Sethuraman , Chief Financial Officer Kory James Wentworth , and director & President and CEO Dipal Doshi .
Entrada Therapeutics Inc (TRDA) Insider Trades Summary
Over the past 18 months, Nathan J Dowden made 7 insider transaction in Entrada Therapeutics Inc (TRDA) with a net sale of 56,124. Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 12,900 shares made by Dipal Doshi , a net sale of 49,989 shares made by Kory James Wentworth , and a net purchase of 45,368 shares made by Peter S Kim .
In summary, during the past 3 months, insiders sold 37,284 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 37,284 shares. During the past 18 months, 188,553 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 143,185 shares.
Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entrada Therapeutics Inc Insider Transactions
Nathan J Dowden Mailing Address
Above is the net worth, insider trading, and ownership report for Nathan J Dowden. You might contact Nathan J Dowden via mailing address: 6 Tide Street, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
